Savage Soul

  Menkes disease, a rare X-linked genetic disorder affecting copper metabolism caused by mutations in ATP7A gene, leads to impaired absorption and transport of dietary copper in the body. Patients suffering from Menkes disease exhibit neurodegenerative features and connective tissue abnormalities. Drug treatment options such as copper histidine, copper chloride, and zinc acetate are used to manage the symptoms of Menkes disease. The Menkes Disease Market is estimated to be valued at US$ 165.1 million in 2024 and is expected to exhibit a CAGR of 6.6% over the forecast period of 2024-2031. The need for drugs to manage copper deficiency and improve health outcomes in patients suffering from Menkes disease is driving market growth. Key Takeaways Key players operating in the Menkes disease drug treatment market are Fortress Biotech, Inc., Teva Pharmaceutical Industries Ltd.,Amerigen Pharmaceuticals Limited, Mylan N.V., Bausch Health Companies Inc. Fortress Biotech is advancing a ge

The medical suction devices market includes products used for removing gases, fluids, vomit, or secretions from the respiratory tract, including the mouth, pharynx, trachea, bronchi or lungs. There are various types of medical suction devices available in the market including electric suction machines, battery-powered portable suction machines and disposable/single use suction catheters. These suction devices find applications during surgical procedures, in emergency care situations, in ICUs and in home care settings for patients requiring respiratory care. With rising cases of respiratory diseases, growing elderly population suffering from chronic obstructive pulmonary diseases and the continued prevalence of COVID-19, demand for medical suction devices is surging. This has prompted manufacturers to advance their products by incorporating features including variable suction control, bacteria filters and compatibility with oxygen therapy. The Medical Suction Devices Market is estimat

Malabsorption syndrome refers to a group of disorders where the small intestine does not absorb enough nutrients, vitamins or minerals from food. The most common causes of malabsorption syndrome are celiac disease, inflammatory bowel disease (IBD), pancreatic insufficiency and short bowel syndrome. The growing prevalence of digestive disorders such as celiac disease and IBD along with increasing demand for targeted medications to treat underlying causes are key factors fueling the demand for malabsorption syndrome treatments. The Malabsorption Syndrome Market is estimated to be valued at US$ 3.42 Bn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024-2031. Key Takeaways Key players operating in the malabsorption syndrome market are AbbVie Inc., Immunogen X, LLC, Astra Zeneca, ImmusanT, Inc., Ritter Pharmaceuticals. These players are focused on developing novel therapeutics and expand their geographic presence globally. The growing prevalence of auto

Liver cirrhosis refers to scarring of the liver caused by long-term liver damage and disease. Some of the common causes include excessive alcohol consumption, viral hepatitis, non-alcoholic fatty liver disease and others. Treatment for liver cirrhosis involves management of symptoms, treatment of underlying cause and mitigating further liver damage. The Liver Cirrhosis Market is primarily driven by increasing prevalence of chronic liver diseases and technological advancements in treatment options. The Liver Cirrhosis Market is estimated to be valued at US$ 1.41 Bn in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024-2031. Liver cirrhosis treatment products aim to minimize liver damage, prevent further scarring and prolong survival. Some of the key products in the market include antiviral drugs, alcohol deterrent medications, corticosteroids, chemotherapy and liver transplantation. With rising healthcare expenditure and improved access to diagnosis and c

Ophthalmoplegia refers to a paralysis of one or more of the extraocular muscles that are involved in eye movement. The condition is often caused due to various factors such as myasthenia gravis, thyroid eye disease, brainstem lesions, or nerve damage during surgeries. Some of the key symptoms of ophthalmoplegia include double vision, ocular misalignment, inability to fully move the eyes in certain directions, etc. The rising prevalence of various eye diseases and disorders that can potentially lead to ophthalmoplegia is driving the need for effective treatment options. The global ophthalmoplegia market witnesses high demand for advanced medications, surgical techniques, and eye exercise therapies for managing the condition. The market is estimated to be valued at US$ 510 Mn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024-2031. Key Takeaways Key players operating in the Global Ophthalmoplegia Market are Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd.

The catering to this market include monoclonal antibodies, liposomes, nanoparticles, receptor-mediated transcytosis, and iontophoresis which aid in transporting different therapeutic agents across the blood brain barrier for treating neurological conditions such as meningitis, multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, and brain tumors. The need for such solutions arises due to the inability of large molecule drugs and over 98% of small molecule drugs to cross the blood brain barrier. The Global Blood Brain Barrier Market is estimated to be valued at US$ 36.2 Mn in 2024 and is expected to exhibit a CAGR of 49% over the forecast period 2024-2031. Key Takeaways Key players operating in the global blood brain barrier market are Denali Therapeutics, JCR Pharmaceuticals, Cyclenium Pharma, Lauren Sciences, biOasis Technologies. Denali Therapeutics is a leading biotech company focusing on developing treatments for neurodegenerative diseases. JCR Pha

Cell cytometry technologies help in characterization, counting and sorting of cells based on their physical and chemical properties including size, shape and internal complexity. Cell cytometry finds applications across various disciplines including stem cell research, immunology, cancer research, transplant quality control, and clinical diagnostics. The technique allows multiparametric analysis of individual cells at a high speed and helps in gaining a better understanding of cells at the single cell level. Rising adoption of cell culture techniques across industries such as biotechnology and pharmaceutical is anticipated to drive the growth of the cell cytometry market during the forecast period. The Cell Cytometry Market is estimated to be valued at US$ 1.5 Bn in 2024 and is expected to exhibit a CAGR of 9.9% over the forecast period 2024-2031. Key Takeaways Key players operating in the cell cytometry market are Agilent, Beckton Dickinson, Beckman Coulter Life Sciences, Bio-Ra

  Bullous pemphigoid is an acquired autoimmune disease that causes blistering of the skin and mucosal membranes. The disease commonly affects people aged 60 years and above and is characterized by the presence of large, thick-walled blisters on the skin. Bullous pemphigoid blisters are fluid-filled and usually occur in clusters and are generally not painful. However, they can rupture easily leading to open sores. The exact causes for bullous pemphigoid are unknown but it is believed to occur due to the immune system attacking skin proteins. Diagnosis involves examination of skin for blisters and testing skin samples. Treatment depends on the severity of symptoms and primarily involves use of corticosteroids and immunosuppressant drugs that target the immune system. The Bullous Pemphigoid Market is estimated to be valued at US$ 1.4 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024-2031. Key Takeaways Key players operating in the Bullous Pemphigoid Mark

  The Botanicals Market is experiencing significant growth owing to rising customer preference for natural ingredients in cosmetics, personal care and food & beverage products. Botanical extracts offer various functional benefits and help manufacturers formulate natural products. They are sourced from plants and contain active pharmacological compounds along with antioxidants that protect cells from damage. The increasing consumer awareness about benefits of botanicals is a major factor prompting brands to expand their natural product lines. The Botanicals Market is estimated to be valued at US$ 112.31 billion in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period 2024-2031. Botanical extracts are used across industries like cosmetics, personal care, food & beverage, pharmaceuticals and nutraceuticals. They provide anti-aging properties, enhance skin texture, treat acne and aid overall skincare. In the food sector, botanicals help fortify products with

The growth of the solar in the United States has caused challenges with land availability and usage. However, a new technique known as agrivoltaics allows for dual land use that can benefit both solar energy production and agriculture. What Is Agrivoltaics?   Agrivoltaics, also known as agrophotovoltaics, involves incorporating solar photovoltaic panels into agricultural areas to allow crops to be grown underneath or amongst the solar panels. This dual land use approach provides multiple benefits over traditional ground-mounted solar farms that occupy agricultural land. With agrivoltaics, farmers can continue crop cultivation on the same plots of land that host solar panels above.   Benefits Of Shade For Crops Many crops have been found to grow better under the partial shade provided by solar panels compared to being in full sun. The shade reduces soil evaporation and moderates temperature fluctuations, providing a more favorable microclimate for certain crops. Research has shown

Candy making has deep roots in American history dating back to the colonial period. Some of the earliest candy recipes originated from European immigrants who brought their candy traditions with them. Traditional candy recipes from Britain, France, Italy, and the Netherlands were adapted to ingredients available in North America. Early American colonists produced homemade candies, often using maple syrup or sorghum as a sweetener before cane sugar was widely available. In the 1800s, candy shops in large cities began commercial production of sweets. Famous US candy brands emerged in the later 19th century as machinery allowed for mass production. Brands like Brach's, Cracker Jack, and Tootsie Roll got their start during this time period and are still going strong today. Candy was also becoming more affordable and accessible for the average American consumer. Chocolate Dominates   Chocolate is by far the biggest selling candy category in the United States Candy  today. Chocolate c